scholarly journals Upaya yang Dilakukan Diabetisi yang Menggunakan BPJS dalam Mengendalikan Gula Darah.

2019 ◽  
Vol 11 (02) ◽  
pp. 1-15
Author(s):  
Maria Paulina Irma Susanti
Keyword(s):  
Blood Sugar ◽  
Type Ii Diabetes ◽  
Phenomenological Approach ◽  
Lifestyle Changes ◽  
The Body ◽  
Type Ii ◽  
Laboratory Measurements ◽  
Key Factor ◽  
Research Questions ◽  
Depth Interviews

Diabetes Mellitus is a chronic metabolic disease in which people with diabetes can not produce enough insulin or the body is unable to use insulin effectively resulting in excess sugar in the blood. Good blood sugar control is a key factor in preventing complications. This can be achieved by administering antidiabetic drugs, lifestyle changes, as well as regular blood glucose and laboratory measurements. Although research on the experience of people with diabetes in controlling blood sugar has been overwhelming, there remains a need to differentiate between factors and processes involved in other blood sugar controls such as the process in the use of BPJS for people with diabetes and gain experience of people with Type II diabetes who use BPJS in controlling blood sugar . This research is a qualitative research with  4 participants of BPJS users. The interviews were structured thematicly analyzed using a phenomenological approach. The result of the research is the exploration of the utilization of people with diabetes in controlling blood sugar, obstacles felt by people with BPJS in controlling Blood sugar, the attempts made by people with BPJS in controlling blood sugar. So it can be concluded that the theme obtained from the results of in-depth interviews can answer research questions that experience diabetisi using BPJS in controlling blood sugar require special efforts in the form of  5 pillars of sustainable DM so that BPJS utilization can be implemented as well as possible. It is also recommended for people with diabetes to better understand the flow of reference / use of BPJS as a basis for controlling blood sugar maximum.  

scholarly journals Senam Prolanis Dm Dan Jalan Kaki Terhadap Penurunan Kadar Gula Darah Pada Penderita Diabetes Millitus Tipe II Di Klinik UMP Purwokerto

2021 ◽  
Vol 6 (2) ◽  
pp. 94
Author(s):  
Agus Sutiono ◽  
Dedy Purwito
Keyword(s):  
Diabetes Mellitus ◽  
Blood Sugar ◽  
Blood Sugar Level ◽  
The Body ◽  
Rank Test ◽  
Type Ii ◽  
Signed Rank ◽  
Signed Rank Test ◽  
Sugar Levels ◽  
Blood Glucose Monitor

Diabetes mellitus is one of cronical degenerative disease. The prevalence of sufferers continues to increase every year, one of the non-pharmacological therapies is exercise such as gymnastics prolanis DM and walking exercises to decrease the glucose level by the body muscles during the physical body. Objective this research is to find out the effectiveness of Prolanis and walking exercises in reducing blood sugar levels in DM patients type II. Method this study uses the Quasi experiment with pre and post with two group design. The study population was 92 DM patients type II with a sample of 82 people. Glucometer (Auto check blood glucose monitor) is used to collect the data. Wiloxon Test is used to analyze the statistical data. Results the research shows that the value of Prolanis Exercises (DM) is p=0.002 which means a significant influence on decrease of the sugar level of DM patients type II. Meanwhile the value of walking exercises is p=0.001. From the statistic test of WIlconxon Signed Rank Test, It obtained Z correlation = 7.886. It means that there is a significant correlation between Prolanis and walking exercises towards the decrease of blood sugar level of Diabetes Mellitus patients type II. Physical activities done regularly, measurably, and correctly are suggested to be considered as non-pharmacological therapies for Diabetes Mellitus patients type II to decrease blood sugar level. Keywords: Prolanis Exercises (DM), Walking, sugar blood level.

scholarly journals Outcome of breast cancer patients regarding obesity and complications: Analysis of risk factors

2021 ◽  
Vol 68 (1) ◽  
pp. 77-86
Author(s):  
Iuliana Pantelimon ◽  
◽  
Laurentia Nicoleta Gales ◽  
Maria Daniela Tanasescu ◽  
Irina Nita ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Body Mass Index ◽  
Prognostic Factors ◽  
Disease Progression ◽  
Body Mass ◽  
Type Ii Diabetes ◽  
The Body ◽  
Proliferation Index ◽  
Her2 Overexpression ◽  
Type Ii

Introduction. Breast cancer is the leading cause of cancer death in Romania. In the context in which the treatments available for this pathology have increased curability, the identification of negative prognostic factors involved in the evolution of this disease seems essential to improve the overall survival as well as the time to disease progression. Aim. The aim of this study is to identify the role of prognostic factors such as ki67 proliferation index, the presence of tumour estrogen receptors, HER2 overexpression, the presence of secondary determinations at diagnosis, the association of obesity and type II diabetes. Methods. 50 patients diagnosed with breast cancer treated in the Elias University Emergency Hospital Bucharest were retrospectively followed, for which the progression was documented at the time of elaboration of this study. Thus, a database was developed in which data were entered on age, body mass index, immunohistochemical characteristics of breast tumours, the presence/absence of metastases at diagnosis and the association of type II diabetes. Statistical calculations were performed to highlight a possible correlation between obesity (quantified by measuring body mass index) and tumour aggressiveness (quantified by ki67 proliferation index) as well as statistical evaluation of potential prognostic factors that would influence time, until the disease progresses. Results. Within this group, no correlation could be established between the presence of an increased body mass index and the value of the ki67 proliferation index (p = 0.38). The mean value of the body mass index for this group of unselected patients was 28.76 ± 4.81 (DS) most patients are therefore overweight or obese. The factors involved in the evolution of breast cancer that influenced the early progression of the disease were: the proliferation index ki67 (p <0.05), the presence of metastases at diagnosis (p < 0.0001) and the association of type II diabetes (p = 0.0085). The value of the body mass index did not influence the time to disease progression according to statistical calculations in this group probably due to the small number of normal weight patients included (p = 0.34).

Relationship between Netrin-1 Levels and Diabetes Mellitus Type 2

2021 ◽  
Vol 19 (10) ◽  
pp. 29-33
Author(s):  
Dr. Mohammed Abdulrazzaq Assi ◽  
Dr. Hanan Jasim Hammood ◽  
Zainab Mahdi Attia
Keyword(s):  
Diabetes Mellitus ◽  
Type Ii Diabetes ◽  
Diabetes Mellitus Type 2 ◽  
Fasting Blood Glucose ◽  
The Body ◽  
Blood Cholesterol ◽  
Control Group ◽  
Type Ii ◽  
Significant Drop

Objects: The study's purpose was to see if there was a link between netrin.1 and type II diabetes patients. Methodology: The present study carried out on (45) patients affected with diabetes mellitus from (120) persons were examined in the education of Diwaniyah hospital from 6th September to the 4th December 2020. The study includes measurement of the body mass index, fasting blood glucose level, HbA1c, lipid profile and level of netrin-1. Results: Our findings were revealed the netrin-1 level was significantly lower in the diabetes (1205.36±753.09) compared to control group (1477.79±700.26; P < 0.01). Our observations were appeared Significantly higher levels of blood cholesterol, TG, LDL, and VLDL-C and In diabetes individuals, there was a significant drop There was a 0.05 difference in HDL-C levels when compared to healthy controls. Conclusion: These findings indicate that low netrin1 concentration in serum are strongly linked to the occurrence of type II diabetes.

scholarly journals Human microbiome as a source of folate modifiable by nutritional and non-nutritional factors

2019 ◽  
Vol 65 (2) ◽  
Author(s):  
Dorota Gumiela
Keyword(s):  
Folic Acid ◽  
Type Ii Diabetes ◽  
Dietary Habits ◽  
Immune Status ◽  
Human Microbiome ◽  
Type Ii ◽  
Nutritional Factors ◽  
Acid Diet ◽  
Key Factor ◽  
Microbial Strains

Hippocrates, in 400 years before our era, indicated that the intestines are central to human health and that “bad digestion is the root of all evil”. The microbiome influences immune status, protects against colonization by pathogenic microorganisms, performs metabolic and trophic functions, and participates in the synthesis of vitamin K, B1, B6, B12, and folic acid. Diet is a key factor in determining its composition. For many microbial strains, p-aminobenzoic acid is an indispensable substrate for the formation of folates. Bifidobacteria (HRB) strains in humans are mainly responsible for the synthesis of folates. Non-HRB strains that have the ability to synthesize folates include B. thermophilum and B. longum ssp. The only hitherto indicated factor that can affect the microbiota’s potential for folate synthesis is metformin, which improves glucose tolerance in people with type II diabetes. Metformin reduces the production of glucose in the liver by inhibiting gluconeogenesis and glycogenolysis, increases the sensitivity of tissues to insulin, and reduces the absorption of glucose. In order to thoroughly understand the ability of the microbiota to synthesize folic acid, it is necessary to conduct studies that include people with varying degrees of exposure to factors that may affect health, such as: poor dietary habits, smoking, low physical activity, diet-related diseases, or taking medications.

scholarly journals Clinical evaluation of an Ayurvedic Formulation in the management of Avaranajanya Madhumeha (Type 2 Diabetes Mellitus)

2019 ◽  
Vol 1 ◽  
pp. 50-64
Author(s):  
DEVASHISH BHARDWAJ ◽  
VEENIT K. AGNIHOTRI ◽  
PRANAV PANDYA
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Blood Sugar ◽  
Type Ii Diabetes ◽  
Type Ii Diabetes Mellitus ◽  
Type Ii ◽  
Research Plan ◽  
Urine Sugar ◽  
Diabetes Patients

A research plan has been developed in the present study to address the problems associated with Avaranajanya Madhumeha (type 2 diabetes). This research plan is based on the treatment methods of Ayurveda (ancient Indian medicine) and utilization of modern scientific methods as research tools. A specific ayurvedic herbo-mineral formulation has been prepared in Ghansatt (solid extract) form; the selected eight herbs and one herbo-mineral have anti-hyperglycemic (PRAMEHA HARA) and antihypercholestermic (MEDOHARA) properties with rejuvenative (RASAYANA) effects as described in classical ayurvedic methods. 15 diagnosed type II diabetes mellitus patients were selected through accidental sampling. Ayurvedic formulation was prescribed to type II diabetes patients for one year along with dietary restrictions. Diabetic diagnostic parameters of these patients like Fasting Blood Sugar (FBS), Post Patrum Blood Sugar (PPBS), Glycocylated Hemoglobin (HbA1C) and Urine Sugar Fasting were monitored every three months; these were measured before and after intervention. The obtained data were statistically analyzed through paired t-test. There was significant reduction in FBS level, PPBS level, HbA1C level and urine fasting sugar level in type 2 diabetes patients who completed the clinical trial successfully. Thus, ayurvedic formulation treatment lead to an overall significant reduction in blood sugar and urine sugar levels in type II diabetes patients. No side effects were noted during the study period. This study suggests that the ayurvedic formulation had very good hypoglycemic effects proved by clinical improvement and bio-chemical analysis of diabetes parameters in the treatment of type II diabetes mellitus.

scholarly journals Newly diagnosed type II diabetes mellitus presenting with localized itch

2020 ◽  
Vol 8 (5) ◽  
pp. 1878
Author(s):  
Talib Mearza ◽  
Wesam Abou Amer ◽  
Maryam Al Jaber
Keyword(s):  
Diabetes Mellitus ◽  
Insulin Resistance ◽  
Dietary Intake ◽  
Blood Sugar ◽  
Type Ii Diabetes ◽  
Type Ii Diabetes Mellitus ◽  
Type Ii ◽  
Newly Diagnosed ◽  
Cutaneous Manifestations ◽  
Sugar Levels

Type II diabetes is caused by insulin resistance resulting in high blood sugar levels. Although the typical symptoms of diabetes are described as polyuria, polydipsia and fatigue as many as 60% of newly diagnosed patients with type II diabetes are asymptomatic. Here authors present a case of a 39-year-old male patient who presented with localized pruritus affecting the medial aspects of his forearms and upper legs as the sole symptom of newly diagnosed type II diabetes mellitus. The itch symptom markedly improved on significantly reducing his dietary intake of sugars and with the use of metformin. Authors hope to alert clinicians to consider the possibility of underlying diabetes in such presentations to enable swift diagnosis and consequent treatment. It is unusual to find patients presenting with localized itch without any corresponding cutaneous manifestations as a presentation of type II diabetes.

Sign in / Sign up

Export Citation Format

Share Document